Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
Clinical trial NCT03319901 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03319901
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2025-11-25
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.